These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 4646433)

  • 1. [Disulfiram and L-dopa in patients with Parkinson's syndrome and in torsion dystonia].
    Serrano PA; Irigoyen M
    Prensa Med Mex; 1972; 37(7):246-50. PubMed ID: 4646433
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of a dihydromorphanthridine derivative in Parkinson's patients treated with L-dopa. A preliminary report.
    Wycis HT
    Confin Neurol; 1972; 34(2):130-5. PubMed ID: 4666056
    [No Abstract]   [Full Text] [Related]  

  • 3. The clinical use of levodopa in the treatment of Parkinson's disease.
    McDowell FH; Markham CH; Lee JE; Treciokas LJ; Ansel RD
    Contemp Neurol Ser; 1971; 8():175-201. PubMed ID: 4950056
    [No Abstract]   [Full Text] [Related]  

  • 4. [Efficacy and side effects of L-dopa in patients with Parkinson's syndrome].
    Lombardo L
    Arch Invest Med (Mex); 1973; 4(3):215-24. PubMed ID: 4784173
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of fusaric acid in Parkinson's disease.
    Herskovits E; Figueroa Gacitua E
    Medicina (B Aires); 1973; 33(1):51-8. PubMed ID: 4573120
    [No Abstract]   [Full Text] [Related]  

  • 6. [Management of Parkinson's syndrome using levadopa. Results of a long-term study].
    Wälzholz U
    Dtsch Med Wochenschr; 1972 Apr; 97(17):686 passim. PubMed ID: 4554502
    [No Abstract]   [Full Text] [Related]  

  • 7. A double-blind controlled study of MK-486 in Parkinson's disease.
    Schwartz AM; Olanow CW; Spencer A
    Trans Am Neurol Assoc; 1973; 98():301-3. PubMed ID: 4594189
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug induced dystonia tarda: treatment with L-dopa.
    Keegan DL; Rajput AH
    Dis Nerv Syst; 1973 Mar; 34(3):167-9. PubMed ID: 4146031
    [No Abstract]   [Full Text] [Related]  

  • 9. [L-DOPA therapy of deforming muscular dystonia in children].
    Mel'nichuk PV; Sosnovskaia LS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(10):1495-8. PubMed ID: 4775332
    [No Abstract]   [Full Text] [Related]  

  • 10. Preliminary clinical studies with L-prolyl-L-leucyl-glycine amide in Parkinson's disease.
    Kastin AJ; Barbeau A
    Can Med Assoc J; 1972 Dec; 107(11):1079-81. PubMed ID: 4640811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Quantitative testing methods for objectification of the effect of prolonged L-dopa therapy in parkinsonism].
    Gerstenbrand F; Grünberger J; Schubert H
    Nervenarzt; 1973 Aug; 44(8):428-33. PubMed ID: 4733895
    [No Abstract]   [Full Text] [Related]  

  • 12. [Personal experience in the treatment of Parkinson's disease with L-Dopa].
    Figuerido JA; De la Herrán J
    Rev Clin Esp; 1970 Dec; 119(6):555-62. PubMed ID: 5509794
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapy of Parkinson's syndrome with L-dopa and a decarboxylase inhibitor (Ro 4-4602). Course in 71 patients].
    Ferel D
    Schweiz Med Wochenschr; 1972 Jan; 102(3):88-94. PubMed ID: 4551909
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of Parkinson's syndrome with L-dopa and a decarboxylase inhibitor].
    Lombardo L; de la Garza R; Ivan-Reynoso G
    Arch Invest Med (Mex); 1974; 5(2):105-16. PubMed ID: 4433198
    [No Abstract]   [Full Text] [Related]  

  • 15. The role of a dihydromorphanthridine derivative in Parkinson's patients treated with L-dopa. A preliminary report.
    Wycis HT
    Confin Neurol; 1972; 34(1):130-5. PubMed ID: 5084387
    [No Abstract]   [Full Text] [Related]  

  • 16. A double-blind crossover study of the L-dopa treatment of torsion dystonia in identical twins.
    Coleman M; Eldridge R; Samler L
    Neurology; 1970 Apr; 20(4):377. PubMed ID: 4935023
    [No Abstract]   [Full Text] [Related]  

  • 17. The influence of a previous thalamotomy on the L-dopa effects on mono-manual dexterity in parkinsonism.
    Knutsson E; Mårtensson A; Meyerson BA; Risberg AM
    Scand J Rehabil Med; 1973; 5(3):130-3. PubMed ID: 4754551
    [No Abstract]   [Full Text] [Related]  

  • 18. Preliminary observations on L-dopa in the treatment of Parkinson's disease.
    Jelsma F; Roth R; Ross P; Davis J
    J Ky Med Assoc; 1971 Apr; 69(4):265-9. PubMed ID: 5577419
    [No Abstract]   [Full Text] [Related]  

  • 19. Parkinson's disease; modern treatment.
    Tolosa E
    Minn Med; 1973 Jun; 56(6):497-502. PubMed ID: 4575903
    [No Abstract]   [Full Text] [Related]  

  • 20. Short-latency median nerve somatosensory evoked potentials in three cases of parkinsonism and dopa responsive dystonia.
    Margari L; de Mari M; Lamberti P; Iliceto G; Serlenga L; Perniola T; Rossini PM; Ferrari E
    Funct Neurol; 1995; 10(2):99-105. PubMed ID: 7557558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.